Dec 14, 2007CompletedNCT00511238: Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaRRMM Relapsed and Refractory Multiple Myeloma NCT00511238: Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma...